A detailed history of Southland Equity Partners LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Southland Equity Partners LLC holds 6,932 shares of ABT stock, worth $799,259. This represents 0.19% of its overall portfolio holdings.

Number of Shares
6,932
Previous 5,536 25.22%
Holding current value
$799,259
Previous $575 Million 37.39%
% of portfolio
0.19%
Previous 0.16%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$100.07 - $118.13 $139,697 - $164,909
1,396 Added 25.22%
6,932 $790 Million
Q2 2024

Jul 12, 2024

BUY
$100.73 - $112.44 $58,020 - $64,765
576 Added 11.61%
5,536 $575 Million
Q1 2024

Apr 12, 2024

BUY
$109.52 - $120.96 $5,256 - $5,806
48 Added 0.98%
4,960 $564 Million
Q4 2023

Jan 09, 2024

BUY
$90.19 - $110.4 $10,732 - $13,137
119 Added 2.48%
4,912 $541 Million
Q3 2023

Jan 02, 2024

BUY
$95.53 - $114.62 $74,991 - $89,976
785 Added 19.59%
4,793 $464 Million
Q2 2023

Jan 02, 2024

BUY
$100.78 - $112.29 $131,618 - $146,650
1,306 Added 48.33%
4,008 $437 Million
Q1 2023

Jan 02, 2024

SELL
$96.86 - $114.01 $1,937 - $2,280
-20 Reduced 0.73%
2,702 $274 Million
Q4 2022

Jan 02, 2024

BUY
$95.06 - $111.52 $12,547 - $14,720
132 Added 5.1%
2,722 $299 Million
Q3 2022

Jan 02, 2024

SELL
$96.76 - $112.03 $967 - $1,120
-10 Reduced 0.38%
2,590 $251 Million
Q2 2022

Jan 02, 2024

BUY
$102.07 - $123.37 $12,656 - $15,297
124 Added 5.01%
2,600 $282 Million
Q1 2022

Jan 02, 2024

BUY
$114.02 - $139.04 $3,648 - $4,449
32 Added 1.31%
2,476 $293 Million
Q4 2021

Jan 02, 2024

BUY
$115.53 - $141.46 $1,039 - $1,273
9 Added 0.37%
2,444 $344 Million
Q3 2021

Jan 02, 2024

SELL
$116.66 - $129.06 $29,281 - $32,394
-251 Reduced 9.34%
2,435 $288 Million
Q2 2021

Jan 02, 2024

BUY
$105.79 - $124.53 $16,820 - $19,800
159 Added 6.29%
2,686 $311 Million
Q4 2020

Jan 02, 2024

BUY
$105.0 - $114.42 $265,335 - $289,139
2,527 New
2,527 $277 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $202B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Southland Equity Partners LLC Portfolio

Follow Southland Equity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Southland Equity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Southland Equity Partners LLC with notifications on news.